Theranostics 2018-01-01

MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance

Xin Lai, Shailendra K Gupta, Ulf Schmitz, Stephan Marquardt, Susanne Knoll, Alf Spitschak, Olaf Wolkenhauer, Brigitte M Pützer, Julio Vera

Index: 10.7150/thno.19904

Full Text: HTML

Abstract

High rates of lethal outcome in tumour metastasis are associated with the acquisition of invasiveness and chemoresistance. Several clinical studies indicate that E2F1 overexpression across high-grade tumours culminates in unfavourable prognosis and chemoresistance in patients. Thus, fine-tuning the expression of E2F1 could be a promising approach for treating patients showing chemoresistance.

Latest Articles:

Diagnosis of LVAD Thrombus using a High-Avidity Fibrin-Specific 99mTc Probe

2018-02-02

[10.7150/thno.20271]

LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d

2018-02-02

[10.7150/thno.20846]

Delivery of Sonic Hedgehog Gene Repressed Irradiation-induced Cellular Senescence in Salivary Glands by Promoting DNA Repair and Reducing Oxidative Stress

2018-01-13

[10.7150/thno.23373]

Non-invasive monitoring of in vivo hydrogel degradation and cartilage regeneration by multiparametric MR imaging

2018-01-13

[10.7150/thno.22514]

Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery

2018-01-05

[10.7150/thno.22078]

More Articles...